Cytokinetics, IncorporatedCYTKNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank71
3Y CAGR-30.9%
Year-over-Year Change
Return on equity
3Y CAGR
-30.9%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 119.00% | -72.7% |
| 2024 | 435.49% | +219.7% |
| 2023 | 136.22% | -62.2% |
| 2022 | 360.48% | +508.3% |
| 2021 | -88.29% | +21.4% |
| 2020 | -112.27% | -110.1% |
| 2019 | 1112.66% | +371.5% |
| 2018 | -409.84% | -252.3% |
| 2017 | -116.34% | -767.2% |
| 2016 | 17.44% | - |